AM 251
Cat.No:IA3760 Solarbio
CAS:183232-66-8
Molecular Formula:C22H21Cl2IN4O
Molecular Weight:555.24
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
GPCR & G Protein >
AM 251CAS:183232-66-8
Molecular Formula:C22H21Cl2IN4O
Molecular Weight:555.24
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 183232-66-8 |
Name | AM 251 |
Molecular Formula | C22H21Cl2IN4O |
Molecular Weight | 555.24 |
Solubility | Soluble in DMSO |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD01861181 |
SMILES | O=C(C1=NN(C2=CC=C(Cl)C=C2Cl)C(C3=CC=C(I)C=C3)=C1C)NN4CCCCC4 |
InChIKey | BUZAJRPLUGXRAB-UHFFFAOYSA-N |
InChI | InChI=1S/C22H21Cl2IN4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-7-16(23)13-18(19)24)21(14)15-5-8-17(25)9-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30) |
PubChem CID | 2125 |
Target Point | Cannabinoid Receptor antagonist |
Passage | GPCR & G Protein;Neuronal Signaling |
Background | AM251 is a selective CB1 receptor antagonist. |
Biological Activity | AM251是选择性大麻素1 (CB1) 受体拮抗剂,IC50 为8 nM。AM251也是 GPR55 的激动剂,EC50为39 nM[1-7]。 |
IC50 | 8nM(CB1 receptor)[1] |
Data Literature Source | [1]. Bruno A,et al. Beyond radio-displacement techniques for identification of CB1 ligands: the first application of afluorescence-quenching assay. Sci Rep. 2014 Jan 20;4:3757. [2]. Sharir H,et al. Pharmacological characterization of GPR55,a putative cannabinoid receptor. Pharmacol Ther. 2010 Jun;126(3):301-13. [3]. Thewke D,et al. AM-251 and SR144528 are acyl CoA:cholesterol acyltransferase inhibitors. Biochem Biophys Res Commun. 2009 Apr 3;381(2):181-6. [4]. Carey LM,et al. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase. Mol Pain. 2016 May 13;12. pii: 1744806916649192. [5]. Komaki A,et al. Study the Effect of Endocannabinoid System on Rat Behavior in Elevated Plus-Maze. Basic Clin Neurosci. 2015 Jul;6(3):147-53. [6]. Jiang X,et al. Role of cannabinoid receptor type 1 in tibial and pudendal neuromodulation of bladder overactivity in cats. Am J Physiol Renal Physiol. 2017 Mar 1;312(3):F482-F488. [7]. Sun L,et al. Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation. Eur J Pain. 2017 May;21(5):804-814. |
Unit | Bottle |
Specification | 5mg 10mg 50mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.